Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed
Fired Disney employee allegedly hacked menu system to falsely claim certain foods did not contain peanuts, complaint says
We're hiking our GEHC price target, looking beyond a mixed quarter to next year's catalysts
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
23andMe appoints three new board members following abrupt resignations
McDonald's executives say E. coli outbreak is 'behind us'
